// App-Quantinova.ai

: Incremental Shuttle Walk Test predicts survival in non-Group 1 Pulmonary Hypertension without a ceiling effect

Researchers

Presenter

  • Catherine Billings

Principal Investigators

  • Robert Lewis

  • Judith Hurdman

  • Iain Armstrong

  • Ian Smith

  • Matthew Austin

  • Charlie Elliot

  • Athanasios Charalampopoulos

  • Ian Sabroe

  • Allan Lawrie

  • Roger Thompson

  • Robin Condliffe

  • David Kiely

Medical Centers

  • Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom

  • Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill, Road, Sheffield, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved